Jerry S. Lanchbury
2016
In 2016, Jerry S. Lanchbury earned a total compensation of $2.7M as Chief Scientific Officer at Myriad Genetics, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $512 |
|---|---|
| Non-Equity Incentive Plan | $215,730 |
| Salary | $479,400 |
| Stock Awards | $1,986,563 |
| Other | $11,297 |
| Total | $2,693,502 |
Lanchbury received $2M in stock awards, accounting for 74% of the total pay in 2016.
Lanchbury also received $512 in bonus, $215.7K in non-equity incentive plan, $479.4K in salary and $11.3K in other compensation.
Rankings
In 2016, Jerry S. Lanchbury's compensation ranked 3,623rd out of 14,075 executives tracked by ExecPay. In other words, Lanchbury earned more than 74.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,623 out of 14,075 | 74th |
Division Manufacturing | 1,267 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 390 out of 1,895 | 79th |
Industry group Drugs | 285 out of 1,538 | 82nd |
Industry In Vitro and In Vivo Diagnostic Substances | 6 out of 65 | 91st |
Source: SEC filing on October 12, 2017.
Lanchbury's colleagues
We found four more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2016.